Position in AKBA
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$28,836
New position
Shares Held
25,295
first reported quarter
Ownership
0.009%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#100
of 169 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026R Squared Ltd holds $1,419,676 across 8 Drug Manufacturers - Specialty & Generic names. AKBA ranks #7 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HLN |
Haleon plc
|
50,307 | $469,364 | |
| 2 | ANIK |
Anika Therapeutics, Inc.
|
27,065 | $395,960 | |
| 3 | BCRX |
Biocryst Pharmaceuticals Inc
|
20,263 | $202,630 | |
| 4 | LFCR |
Lifecore Biomedical, Inc. De
|
24,580 | $129,045 | |
| 5 | TLRY |
Tilray Brands, Inc.
|
27,861 | $125,095 | |
| 6 | SIGA |
Siga Technologies Inc
|
14,793 | $53,846 | |
| 7 | AKBA |
Akebia Therapeutics, Inc.
This page
|
25,295 | $28,836 | |
| 8 | ADCT |
ADC Therapeutics SA
|
13,926 | $14,900 |
All Filings in AKBA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,836 | 25,295 | Shares | Sole | 2026-08-05 | |
| No filing history on record for this holder in this stock. | ||||||